Plant-derived extracellular vesicles: emerging carriers for ingestible nucleotide delivery
Expert Opinion on Drug Delivery · 2026
DOI: 10.1080/17425247.2025.2591237 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Expert Opinion on Drug Delivery, 2026. Verfasst von Zhuo Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Harbin University of Commerce, Harbin, Heilongjiang, China. Hauptthemen laut MEDLINE: Extracellular Vesicles, Drug Delivery Systems, Nucleotides, Drug Carriers. Die Arbeit nennt 173 Literaturangaben. Gefördert von: National Natural Science Foundation of China, CAMS Innovation Fund for Medical Sciences, Jilin Scientific and Technological Development Program.
Abstract (Originalsprache)
INTRODUCTION: Plant-derived extracellular vesicles (PEVs) have shown significant promise as a novel oral delivery system for nucleotide-based drugs. The successful oral delivery of nucleotide drugs using PEVs paves the way for developing innovative nucleotide delivery systems in terms of inflammatory bowel disease, cancer and metabolic diseases treatment. By utilizing surface and other engineering modifications, PEVs can circumvent the challenges of oral administration posed by the gastrointestinal barrier and enzymatic degradation. AREAS COVERED: This review covers PEVs as oral nucleotide carriers, focusing on their anti-inflammatory, anticancer, and metabolic disease applications. It includes engineered modification methods (ligand, polymer modification, fusion) and nucleotide delivery application. This review searched for keywords using literature retrieval websites such as PubMed, Embase, and Google Scholar. EXPERT OPINION: This review introduces recent advancements of PEV-based technologies focused on ingestible nucleotide delivery, not only contributing valuable theoretical insights but also offering practical guidance for future precision medicine and drug development by PEVs. However, the current existence of regulatory ambiguity and low production efficiency has hindered the clinical translation and large-scale application of PEV-based oral nucleotide delivery systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Harbin University of Commerce, Harbin, Heilongjiang, China.
- State Key Laboratory for Quality Assurance and Sustainable Use of Dao-di Herbs, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
- Department of Biomedical Engineering, Sungkyunkwan University (SKKU), Suwon, Republic of Korea.
- Department of Intelligent Precision Healthcare Convergence, Sungkyunkwan University (SKKU), Suwon, Republic of Korea.
- College of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Förderung
- National Natural Science Foundation of China
- CAMS Innovation Fund for Medical Sciences
- Jilin Scientific and Technological Development Program
Zitieren
APA
Li, Z., Jin, W., Zhu, M., Feng, Y., Fan, G., Zhao, J., Lee, J. S., Li, X., Li, Y., Lu, Y., & Dong, Z. (2026). Plant-derived extracellular vesicles: emerging carriers for ingestible nucleotide delivery. Expert Opinion on Drug Delivery. https://doi.org/10.1080/17425247.2025.2591237
Vancouver
Li Z, Jin W, Zhu M, Feng Y, Fan G, Zhao J, et al. Plant-derived extracellular vesicles: emerging carriers for ingestible nucleotide delivery. Expert Opinion on Drug Delivery. 2026. doi:10.1080/17425247.2025.2591237
BibTeX
@article{Li2026,
author = {Li, Zhuo and Jin, Wei and Zhu, Minyu and Feng, Yifan and Fan, Guangyu and Zhao, Jixiang and Lee, Jung Seung and Li, Xin and Li, Ying and Lu, Yang and Dong, Zhengqi},
title = {Plant-derived extracellular vesicles: emerging carriers for ingestible nucleotide delivery},
journal = {Expert Opinion on Drug Delivery},
year = {2026},
doi = {10.1080/17425247.2025.2591237}
}
EUVIMED